Giant Biogene Holding Co., Ltd.
2367
Classement en actions
#5026
Giant Biogene Holding Co., Ltd. operates as an investment holding entity,... Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
Prix de l'action
$2.67
Capitalisation boursière
$2.84B
Changement (1 jour)
-6.09%
Changement (1 an)
-46.20%
Pays
CN
Échange Giant Biogene Holding Co., Ltd. (2367)
Catégorie
Consumer Defensive
Ratio P/S pour Giant Biogene Holding Co., Ltd. (2367)
Ratio P/S au October 2026 TTM : 3.59
Selon les derniers rapports financiers et le cours de l'action de Giant Biogene Holding Co., Ltd., le ratio cours/ventes actuel (TTM) est 3.59. À la fin de 2024, le ratio P/S était de 8.47.
Historique du ratio P/S pour Giant Biogene Holding Co., Ltd. de 2019 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| 2026 (TTM) | 3.59 | -37.41% |
| 2025 | 5.73 | -32.35% |
| 2024 | 8.47 | -5.65% |
| 2023 | 8.98 | -26.69% |
| 2022 | 12.25 | -10.30% |
| 2021 | 13.65 | -27.03% |
| 2020 | 18.71 | -24.32% |
| 2019 | 24.72 | 0.00% |
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| 4.28 | 19.25% |
US
|
|
| 4.52 | 26.10% |
FR
|
|
| 3.54 | -1.35% |
US
|
|
| 6.51 | 81.46% |
IN
|
|
| 2.50 | -30.41% |
US
|
